Clinical Trial Update: Efficacy of Dapagliflozin in Diabetes Associated Peripheral Neuropathy [Phase 2, Phase 3]

View source ↗

Summary

A trial update on the efficacy of dapagliflozin for diabetic peripheral neuropathy across Phase 2 and Phase 3, with unclear status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Diabetic Peripheral Neuropathy | Phase 2, Phase 3 | Status: UNKNOWN